Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins

被引:23
|
作者
Abraham, JD
Himoudi, N
Kien, F
Berland, JL
Codran, A
Bartosch, B
Baumert, T
Paranhos-Baccala, G
Schuster, C
Inchauspé, G
Kieny, MP
机构
[1] INSERM, U544, Inst Virol, F-67000 Strasbourg, France
[2] Ecole Normale Super Lyon, CNRS, UMR 2142, BioMerieux, F-69364 Lyon 07, France
[3] CERVI, CNRS, UMR 2142, BioMerieux, F-69364 Lyon 07, France
[4] Ecole Normale Super Lyon, INSERM, U412, IFR 128, F-69364 Lyon 07, France
[5] Univ Freiburg, Dept Med 2, Freiburg, Germany
关键词
HCV; MVA; immunization; humoral and cellular responses;
D O I
10.1016/j.vaccine.2004.04.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have evaluated in C57[1316 and HLA-A2.1 transgenic mice the immunogenicity of three MVA vectors expressing either native HCV El E2 polyprotein. truncated and secreted El (E'1 (311)) and E2 (E'2(661)) proteins, or a chimeric El E2 heterodimer presented at the plasma membrane. Immunization induced mainly a Th1 response in HLA-A2.1 transgenic mice while a Th2-type response was detected in C57/B16 mice. Comparison of the three vectors shows an increase in the humoral response when antigens are secreted or membrane bound, and slightly in the cellular response when antigens are exposed on the cell surface. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3917 / 3928
页数:12
相关论文
共 33 条
  • [21] Persistent replication of a hepatitis C virus genotype 1b-based chimeric clone carrying E1, E2 and p6 regions from GB virus B in a New World monkey
    Suzuki, Saori
    Mori, Ken-ichi
    Higashino, Atsunori
    Iwasaki, Yuki
    Yasutomi, Yasuhiro
    Maki, Noboru
    Akari, Hirofumi
    MICROBIOLOGY AND IMMUNOLOGY, 2016, 60 (01) : 26 - 34
  • [22] The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
    Calvo-Pinilla, Eva
    Gubbins, Simon
    Mertens, Peter
    Ortego, Javier
    Castillo-Olivares, Javier
    ANTIVIRAL RESEARCH, 2018, 154 : 132 - 139
  • [23] E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox
    Volz, Asisa
    Jany, Sylvia
    Freudenstein, Astrid
    Lantermann, Markus
    Ludwig, Holger
    Sutter, Gerd
    VIRUSES-BASEL, 2018, 10 (01):
  • [24] Multiplex flow cytometry-based assay to study the breadth of antibody responses against E1E2 glycoproteins of hepatitis C virus
    Merat, Sabrina J.
    van de Berg, Dorien
    Bru, Camille
    Yasuda, Etsuko
    Breij, Esther
    Kootstra, Neeltje
    Prins, Maria
    Molenkamp, Richard
    Bakker, Arjen Q.
    de Jon, Menno D.
    Spits, Hergen
    Schinkel, Janke
    Beaumont, Tim
    JOURNAL OF IMMUNOLOGICAL METHODS, 2018, 454 : 15 - 26
  • [25] Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein
    Heo, Tae-Hwe
    Lee, Song-Mi
    Bartosch, Birke
    Cosset, Francois-Loic C.
    Kang, Chang-Yuil
    VIRUS RESEARCH, 2006, 121 (01) : 58 - 64
  • [26] Determination of the Human Antibody Response to the Neutralization Epitopes Encompassing Amino Acids 313-327 and 432-443 of Hepatitis C Virus E1E2 Glycoproteins
    Liu, Ruyu
    Rao, Huiying
    Wang, Jianghua
    Xie, Xingwang
    Jiang, Dong
    Pan, Xiaoben
    Zhao, Ping
    Zhang, Henghui
    Wei, Lai
    PLOS ONE, 2013, 8 (06):
  • [27] In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection
    Mailly, Laurent
    Wrensch, Florian
    Heydmann, Laura
    Fauvelle, Catherine
    Brignon, Nicolas
    Zeisel, Mirjam B.
    Pessaux, Patrick
    Keck, Zhen-yong
    Schuster, Catherine
    Fuerst, Thomas R.
    Foung, Steven K. H.
    Baumert, Thomas F.
    ANTIVIRAL RESEARCH, 2019, 162 : 136 - 141
  • [28] A Novel Approach To Display Structural Proteins of Hepatitis C Virus Quasispecies in Patients Reveals a Key Role of E2 HVR1 in Viral Evolution
    Tong, Yimin
    Li, Qingchao
    Li, Rui
    Xu, Yongfen
    Pan, Yu
    Niu, Junqi
    Zhong, Jin
    JOURNAL OF VIROLOGY, 2020, 94 (17)
  • [29] Stability of the HSV-2 US-6 Gene in the del II, del III, CP77, and I8R-G1L Sites in Modified Vaccinia Virus Ankara After Serial Passage of Recombinant Vectors in Cells
    Atukorale, Vajini N.
    Weir, Jerry P.
    Meseda, Clement A.
    VACCINES, 2020, 8 (01)
  • [30] Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2α
    Backes, Simone
    Sperling, Karin M.
    Zwilling, Joachim
    Gasteiger, Georg
    Ludwig, Holger
    Kremmer, Elisabeth
    Schwantes, Astrid
    Staib, Caroline
    Sutter, Gerd
    JOURNAL OF GENERAL VIROLOGY, 2010, 91 : 470 - 482